1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Gram-Negative Bacterial Infection Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Enteral Treatment 1.2.3 Parenteral Treatment 1.2.4 Topical Treatment 1.3 Market by Application 1.3.1 Global Gram-Negative Bacterial Infection Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Gram-Negative Bacterial Infection Therapeutics Market Perspective (2016-2027) 2.2 Gram-Negative Bacterial Infection Therapeutics Growth Trends by Regions 2.2.1 Gram-Negative Bacterial Infection Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Gram-Negative Bacterial Infection Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Gram-Negative Bacterial Infection Therapeutics Industry Dynamic 2.3.1 Gram-Negative Bacterial Infection Therapeutics Market Trends 2.3.2 Gram-Negative Bacterial Infection Therapeutics Market Drivers 2.3.3 Gram-Negative Bacterial Infection Therapeutics Market Challenges 2.3.4 Gram-Negative Bacterial Infection Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Gram-Negative Bacterial Infection Therapeutics Players by Revenue 3.1.1 Global Top Gram-Negative Bacterial Infection Therapeutics Players by Revenue (2016-2021) 3.1.2 Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Gram-Negative Bacterial Infection Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Gram-Negative Bacterial Infection Therapeutics Revenue 3.4 Global Gram-Negative Bacterial Infection Therapeutics Market Concentration Ratio 3.4.1 Global Gram-Negative Bacterial Infection Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Gram-Negative Bacterial Infection Therapeutics Revenue in 2020 3.5 Gram-Negative Bacterial Infection Therapeutics Key Players Head office and Area Served 3.6 Key Players Gram-Negative Bacterial Infection Therapeutics Product Solution and Service 3.7 Date of Enter into Gram-Negative Bacterial Infection Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Gram-Negative Bacterial Infection Therapeutics Breakdown Data by Type 4.1 Global Gram-Negative Bacterial Infection Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Type (2022-2027) 5 Gram-Negative Bacterial Infection Therapeutics Breakdown Data by Application 5.1 Global Gram-Negative Bacterial Infection Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Gram-Negative Bacterial Infection Therapeutics Market Size (2016-2027) 6.2 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type 6.2.1 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) 6.2.2 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027) 6.2.3 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2027) 6.3 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application 6.3.1 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021) 6.3.2 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027) 6.3.3 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2027) 6.4 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Country 6.4.1 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021) 6.4.2 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Gram-Negative Bacterial Infection Therapeutics Market Size (2016-2027) 7.2 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type 7.2.1 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2027) 7.3 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application 7.3.1 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2027) 7.4 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Country 7.4.1 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type 8.2.1 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application 8.3.1 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Region 8.4.1 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size (2016-2027) 9.2 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Type 9.2.1 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application 9.3.1 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2027) 9.4 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Country 9.4.1 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type 10.2.1 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application 10.3.1 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Country 10.4.1 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Baxter 11.1.1 Baxter Company Details 11.1.2 Baxter Business Overview 11.1.3 Baxter Gram-Negative Bacterial Infection Therapeutics Introduction 11.1.4 Baxter Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) 11.1.5 Baxter Recent Development 11.2 Sanofi 11.2.1 Sanofi Company Details 11.2.2 Sanofi Business Overview 11.2.3 Sanofi Gram-Negative Bacterial Infection Therapeutics Introduction 11.2.4 Sanofi Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) 11.2.5 Sanofi Recent Development 11.3 GlaxoSmithKline 11.3.1 GlaxoSmithKline Company Details 11.3.2 GlaxoSmithKline Business Overview 11.3.3 GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Introduction 11.3.4 GlaxoSmithKline Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) 11.3.5 GlaxoSmithKline Recent Development 11.4 Novartis 11.4.1 Novartis Company Details 11.4.2 Novartis Business Overview 11.4.3 Novartis Gram-Negative Bacterial Infection Therapeutics Introduction 11.4.4 Novartis Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) 11.4.5 Novartis Recent Development 11.5 Pfizer 11.5.1 Pfizer Company Details 11.5.2 Pfizer Business Overview 11.5.3 Pfizer Gram-Negative Bacterial Infection Therapeutics Introduction 11.5.4 Pfizer Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) 11.5.5 Pfizer Recent Development 11.6 Takeda 11.6.1 Takeda Company Details 11.6.2 Takeda Business Overview 11.6.3 Takeda Gram-Negative Bacterial Infection Therapeutics Introduction 11.6.4 Takeda Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) 11.6.5 Takeda Recent Development 11.7 Nektar Therapeutics 11.7.1 Nektar Therapeutics Company Details 11.7.2 Nektar Therapeutics Business Overview 11.7.3 Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Introduction 11.7.4 Nektar Therapeutics Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) 11.7.5 Nektar Therapeutics Recent Development 11.8 Sumitomo 11.8.1 Sumitomo Company Details 11.8.2 Sumitomo Business Overview 11.8.3 Sumitomo Gram-Negative Bacterial Infection Therapeutics Introduction 11.8.4 Sumitomo Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) 11.8.5 Sumitomo Recent Development 11.9 Targeted Genetics 11.9.1 Targeted Genetics Company Details 11.9.2 Targeted Genetics Business Overview 11.9.3 Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Introduction 11.9.4 Targeted Genetics Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) 11.9.5 Targeted Genetics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Gram-Negative Bacterial Infection Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Enteral Treatment Table 3. Key Players of Parenteral Treatment Table 4. Key Players of Topical Treatment Table 5. Global Gram-Negative Bacterial Infection Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Gram-Negative Bacterial Infection Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Gram-Negative Bacterial Infection Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Regions (2016-2021) Table 9. Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Regions (2022-2027) Table 11. Gram-Negative Bacterial Infection Therapeutics Market Trends Table 12. Gram-Negative Bacterial Infection Therapeutics Market Drivers Table 13. Gram-Negative Bacterial Infection Therapeutics Market Challenges Table 14. Gram-Negative Bacterial Infection Therapeutics Market Restraints Table 15. Global Gram-Negative Bacterial Infection Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Players (2016-2021) Table 17. Global Top Gram-Negative Bacterial Infection Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gram-Negative Bacterial Infection Therapeutics as of 2020) Table 18. Ranking of Global Top Gram-Negative Bacterial Infection Therapeutics Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Gram-Negative Bacterial Infection Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Gram-Negative Bacterial Infection Therapeutics Product Solution and Service Table 22. Date of Enter into Gram-Negative Bacterial Infection Therapeutics Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 25. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Type (2016-2021) Table 26. Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Gram-Negative Bacterial Infection Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Application (2016-2021) Table 30. Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 33. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 35. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 62. Baxter Company Details Table 63. Baxter Business Overview Table 64. Baxter Gram-Negative Bacterial Infection Therapeutics Product Table 65. Baxter Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million) Table 66. Baxter Recent Development Table 67. Sanofi Company Details Table 68. Sanofi Business Overview Table 69. Sanofi Gram-Negative Bacterial Infection Therapeutics Product Table 70. Sanofi Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million) Table 71. Sanofi Recent Development Table 72. GlaxoSmithKline Company Details Table 73. GlaxoSmithKline Business Overview Table 74. GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Product Table 75. GlaxoSmithKline Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million) Table 76. GlaxoSmithKline Recent Development Table 77. Novartis Company Details Table 78. Novartis Business Overview Table 79. Novartis Gram-Negative Bacterial Infection Therapeutics Product Table 80. Novartis Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million) Table 81. Novartis Recent Development Table 82. Pfizer Company Details Table 83. Pfizer Business Overview Table 84. Pfizer Gram-Negative Bacterial Infection Therapeutics Product Table 85. Pfizer Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million) Table 86. Pfizer Recent Development Table 87. Takeda Company Details Table 88. Takeda Business Overview Table 89. Takeda Gram-Negative Bacterial Infection Therapeutics Product Table 90. Takeda Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million) Table 91. Takeda Recent Development Table 92. Nektar Therapeutics Company Details Table 93. Nektar Therapeutics Business Overview Table 94. Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Product Table 95. Nektar Therapeutics Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million) Table 96. Nektar Therapeutics Recent Development Table 97. Sumitomo Company Details Table 98. Sumitomo Business Overview Table 99. Sumitomo Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million) Table 100. Sumitomo Recent Development Table 101. Targeted Genetics Company Details Table 102. Targeted Genetics Business Overview Table 103. Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Product Table 104. Targeted Genetics Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million) Table 105. Targeted Genetics Recent Development Table 106. Research Programs/Design for This Report Table 107. Key Data Information from Secondary Sources Table 108. Key Data Information from Primary Sources List of Figures Figure 1. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Enteral Treatment Features Figure 3. Parenteral Treatment Features Figure 4. Topical Treatment Features Figure 5. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Application: 2020 VS 2027 Figure 6. Hospitals Case Studies Figure 7. Clinics Case Studies Figure 8. Others Case Studies Figure 9. Gram-Negative Bacterial Infection Therapeutics Report Years Considered Figure 10. Global Gram-Negative Bacterial Infection Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Gram-Negative Bacterial Infection Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Regions: 2020 VS 2027 Figure 13. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Regions (2022-2027) Figure 14. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Players in 2020 Figure 15. Global Top Gram-Negative Bacterial Infection Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gram-Negative Bacterial Infection Therapeutics as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Gram-Negative Bacterial Infection Therapeutics Revenue in 2020 Figure 17. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Type (2016-2021) Figure 18. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Type (2022-2027) Figure 19. North America Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Gram-Negative Bacterial Infection Therapeutics Market Share by Type (2016-2027) Figure 21. North America Gram-Negative Bacterial Infection Therapeutics Market Share by Application (2016-2027) Figure 22. North America Gram-Negative Bacterial Infection Therapeutics Market Share by Country (2016-2027) Figure 23. United States Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Gram-Negative Bacterial Infection Therapeutics Market Share by Type (2016-2027) Figure 27. Europe Gram-Negative Bacterial Infection Therapeutics Market Share by Application (2016-2027) Figure 28. Europe Gram-Negative Bacterial Infection Therapeutics Market Share by Country (2016-2027) Figure 29. Germany Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Share by Type (2016-2027) Figure 37. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Share by Application (2016-2027) Figure 38. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Share by Region (2016-2027) Figure 39. China Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Gram-Negative Bacterial Infection Therapeutics Market Share by Type (2016-2027) Figure 47. Latin America Gram-Negative Bacterial Infection Therapeutics Market Share by Application (2016-2027) Figure 48. Latin America Gram-Negative Bacterial Infection Therapeutics Market Share by Country (2016-2027) Figure 49. Mexico Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Share by Type (2016-2027) Figure 53. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Share by Application (2016-2027) Figure 54. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Share by Country (2016-2027) Figure 55. Turkey Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Baxter Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) Figure 59. Sanofi Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) Figure 60. GlaxoSmithKline Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) Figure 61. Novartis Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) Figure 62. Pfizer Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) Figure 63. Takeda Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) Figure 64. Nektar Therapeutics Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) Figure 65. Sumitomo Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) Figure 66. Targeted Genetics Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed

Baxter Sanofi GlaxoSmithKline Novartis Pfizer Takeda Nektar Therapeutics Sumitomo Targeted Genetics